Showing results (21-30 of 58) with videos related to
Sort By:
Pageof 6
Leukemia & Lymphoma|December 23, 2020
Identification of a miRNA based model to detect prognostic subgroups in patients with aggressive B-cell lymphomaCarmen Nordmo, Gunther Glehr, Michael Altenbuchinger, et al.Analytica Chimica Acta|October 16, 2020
Optimized protocol for metabolomic and lipidomic profiling in formalin-fixed paraffin-embedded kidney tissue by LC-MSSylvia K Neef, Stefan Winter, Ute Hofmann, et al.Haematologica|March 1, 2013
Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomasIdoia Martin-Guerrero, Itziar Salaverria, Birgit Burkhardt, et al.Journal of Visualized Experiments : Jove|September 29, 2025
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell LymphomaJulia Thiel, Jan A Schlegel, Sam Steinfeldt, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 13, 2025
Cytogenomic and Clinicopathologic Comparison of MYC-Positive and MYC-Negative High-Grade B-Cell Lymphoma With 11q Aberration in the Context of Other Aggressive Lymphomas With MYC RearrangementBeata Grygalewicz, Lukasz M Szafron, Laura A Szafron, et al.Leukemia & Lymphoma|July 16, 2010
Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conferenceMartin Dreyling, Eva Hoster, Silvia Bea, et al.Blood Advances|November 7, 2023
Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative stressBeatriz Gomez Solsona, Heike Horn, Anja Schmitt, et al.Blood|November 11, 2017
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapyAnja Mottok, Vindi Jurinovic, Pedro Farinha, et al.Histopathology|November 9, 2020
Cytokeratin expression in plasmablastic lymphoma - a possible diagnostic pitfall in the routine work-up of tumoursKatrin S Huettl, Annette M Staiger, Heike Horn, et al.Blood|January 22, 2013
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphomaHeike Horn, Marita Ziepert, Claudia Becher, et al.Pageof 6